We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account

GCP

Home » Topics » Clinical Trials » GCP
  • August 9, 2017

    FDA Warns Clinical Researcher for Enrolling Ineligible Subjects

    The FDA issued a warning letter to a Texas clinical researcher, claiming he deviated from his own investigational plan by enrolling ineligible trial subjects.
  • August 9, 2017

    Clinical Trials Questions; FDA Answers

    The FDA’s rules for clinical investigators cover a lot of ground, from how to avoid financial conflicts of interest, to delegating investigator authority to other members of the trial team, to hiring—and sometimes firing—investigators under your charge. The FDA provides all the GCP regulations and guidances you need to run a clinical trial, but even those documents can’t answer every question you may have about the people who actually conduct the trial.
  • August 9, 2017

    FDA: Three-Parent Baby Technique in Clinical Research is Illegal

    The FDA ruled the use of mitochondrial replacement technology in clinical research is illegal.
Read More
  • April 10, 2017

    Clinical Trial Questions: FDA’s Answers

  • April 13, 2016

    Strategies to Reduce Inefficiency of GCP Training

  • January 21, 2016

    Report: Tweaking Clinical Trial Protocols Takes Toll on Research

  • January 15, 2016

    How Diverse Are Clinical Trials?

  • January 15, 2016

    Report Outlines Risk Factors for Low Enrollment In Cancer Trials

  • January 14, 2016

    Tufts Report Shines Light on Continued Use, Cost of Clinical Trial Protocol Changes

  • January 7, 2016

    Report: One-Fifth of Cancer Clinical Trials Fall Short on Recruitment Goals

  • December 31, 2015

    Risk Factors for Low Enrollment in Cancer Trials Spelled Out

  • December 14, 2015

    EMA Cracks Down on Noncompliant Trials

  • December 14, 2015

    New Project Hopes to Guide Ethical Use of Mobile Devices in Research

Read More

Products

  • The biden administrations fda 500blue 2022

    The Biden Administration’s FDA: A Remarkable 2021, What to Expect in 2022 – Webinar Recording/Transcript

    $337.00
  • David harrison blue5001

    Spreadsheet Validation: Best Practices to Maintain Compliance – Webinar Recording/Transcript

    $287.00
  • The biden administrations fda 500blue

    The Biden Administration’s FDA: The First Six Months and What to Expect for the Rest of the Year – Webinar Recording/Transcript

    $337.00
  • David harrison purple

    Spreadsheet Validation: Best Practices to Maintain Compliance – Webinar Recording/Transcript

    $287.00
More Products

Events

  • 27Jul

    Applying the Lessons of the Pandemic to Your Upcoming Trial

More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing